One function - Multiple mechanisms: The manifold activities of p53 as a transcriptional repressor

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Böhlig, Levin ^a   Rother, Karen ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; REPRESSOR PROTEIN;

BINDING SITE; CELL CYCLE ARREST; CHROMATIN STRUCTURE; GENE CONTROL; GENE INTERACTION; GENE REPRESSION; HUMAN; METHYLATION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955009769     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/464916     Document Type: Review

References (162)

1. Talos F., Moll U. M., Role of the p53 family in stabilizing the genome and preventing polyploidization Advances in Experimental Medicine and Biology 2010 676 73 91
2. Lane D. P., Crawford L. V., T antigen is bound to a host protein in SV40 transformed cells Nature 1979 278 5701 261 263 (Pubitemid 9129076)
3. Linzer D. I. H., Levine A. J., Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells Cell 1979 17 1 43 52 (Pubitemid 9188209)
4. Vogelstein B., Lane D., Levine A. J., Surfing the p53 network Nature 2000 408 6810 307 310
5. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Butel J. S., Bradley A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 1992 356 6366 215 221
6. Ventura A., Kirsch D. G., McLaughlin M. E., Tuveson D. A., Grimm J., Lintault L., Newman J., Reczek E. E., Weissleder R., Jacks T., Restoration of p53 function leads to tumour regression in vivo Nature 2007 445 7128 661 665 (Pubitemid 46232887)
7. Xue W., Zender L., Miething C., Dickins R. A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S. W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas Nature 2007 445 7128 656 660 (Pubitemid 46232886)
8. El-Deiry W. S., Kern S. E., Pietenpol J. A., Kinzler K. W., Vogelstein B., Definition of a consensus binding site for p53 Nature Genetics 1992 1 1 45 49
9. Farmer G., Colgan J., Nakatani Y., Manley J. L., Prives C., Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo Molecular and Cellular Biology 1996 16 8 4295 4304 (Pubitemid 26251231)
10. Liu X., Miller C. W., Koeffler P. H., Berk A. J., The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription Molecular and Cellular Biology 1993 13 6 3291 3300 (Pubitemid 23157267)
11. Lu H., Levine A. J., Human TAF(II)31 protein is a transcriptional coactivator of the p53 protein Proceedings of the National Academy of Sciences of the United States of America 1995 92 11 5154 5158
12. Miyashita T., Reed J. C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 1995 80 2 293 299
13. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B., WAF1, a potential mediator of p53 tumor suppression Cell 1993 75 4 817 825 (Pubitemid 23346378)
14. Hermeking H., Lengauer C., Polyak K., He T. C., Zhang L., Thiagalingam S., Kinzler K. W., Vogelstein B., 14-3-3 is a p53-regulated inhibitor of G2/M progression Molecular Cell 1997 1 1 3 11 (Pubitemid 127376388)
15. Ho J., Benchimol S., Transcriptional repression mediated by the p53 tumour suppressor Cell Death and Differentiation 2003 10 4 404 408 (Pubitemid 36636906)
16. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., Derr J., Taya Y., Lowe S. W., Kastan M., Giaccia A., Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation Molecular and Cellular Biology 2001 21 4 1297 1310 (Pubitemid 32114977)
17. Riley T., Sontag E., Chen P., Levine A., Transcriptional control of human p53-regulated genes Nature Reviews Molecular Cell Biology 2008 9 5 402 412 (Pubitemid 351574202)
18. Shi M., Liu D., Shen B., Guo N., Helpers of the cellular gatekeeper-miRNAs dance in P53 network Biochimica et Biophysica Acta 2010 1805 2 218 225
19. Vousden K. H., Prives C., Blinded by the light: the growing complexity of p53 Cell 2009 137 3 413 431
20. Menendez D., Inga A., Resnick M. A., The expanding universe of p53 targets Nature Reviews Cancer 2009 9 10 724 737
21. Wang B., Xiao Z., Ren EE. C., Redefining the p53 response element Proceedings of the National Academy of Sciences of the United States of America 2009 106 34 14373 14378
22. Johnson R. A., Ince T. A., Scotto K. W., Transcriptional repression by p53 through direct binding to a novel DNA element Journal of Biological Chemistry 2001 276 29 27716 27720
23. Godar S., Ince T. A., Bell G. W., Feldser D., Donaher J. L., Bergh J., Liu A., Miu K., Watnick R. S., Reinhardt F., McAllister S. S., Jacks T., Weinberg R. A., Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression Cell 2008 134 1 62 73 (Pubitemid 351905743)
24. Marks J., Saifudeen Z., Dipp S., El-Dahr S. S., Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter Journal of Biological Chemistry 2003 278 36 34158 34166 (Pubitemid 37553257)
25. Lee K. C., Crowe A. J., Barton M. C., p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding Molecular and Cellular Biology 1999 19 2 1279 1288 (Pubitemid 29046870)
26. Wilkinson D. S., Tsai W. W., Schumacher M. A., Barton M. C., Chromatin-bound p53 anchors activated Smads and the mSin3A corepressor to confer transforming growth factor -mediated transcription repression Molecular and Cellular Biology 2008 28 6 1988 1998 (Pubitemid 351342629)
27. van Bodegom D., Roessingh W., Pridjian A., El Dahr S. S., Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter Biochimica et Biophysica Acta 2010 1799 7 502 509
28. Zaky A., Busso C., Izumi T., Chattopadhyay R., Bassiouny A., Mitra S., Bhakat K. K., Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage Nucleic Acids Research 2008 36 5 1555 1566 (Pubitemid 351426108)
29. Innocente S. A., Lee J. M., p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription FEBS Letters 2005 579 5 1001 1007 (Pubitemid 40248660)
30. Clair S. ST., Giono L., Varmeh-Ziaie S., Resnick-Silverman L., Liu W. J., Padi A., Dastidar J., DaCosta A., Mattia M., Manfredi J. J., DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter Molecular Cell 2004 16 5 725 736 (Pubitemid 39586531)
31. Imbriano C., Gurtner A., Cocchiarella F., Di Agostino S., Basile V., Gostissa M., Dobbelstein M., Del Sal G., Piaggio G., Mantovani R., Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G/M promoters Molecular and Cellular Biology 2005 25 9 3737 3751 (Pubitemid 40559579)
32. Krause K., Haugwitz U., Wasner M., Wiedmann M., Mssner J., Engeland K., Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73 Biochemical and Biophysical Research Communications 2001 284 3 743 750 (Pubitemid 32924792)
33. Manni I., Mazzaro G., Gurtner A., Mantovani R., Haugwitz U., Krause K., Engeland K., Sacchi A., Soddu S., Piaggio G., NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G arrest Journal of Biological Chemistry 2001 276 8 5570 5576
34. Basile V., Mantovani R., Imbriano C., DNA damage promotes histone deacetylase 4 nuclear localization and repression of G/M promoters, via p53 C-terminal lysines Journal of Biological Chemistry 2006 281 4 2347 2357 (Pubitemid 43845826)
35. Le Gac G., Estve P. O., Ferec C., Pradhan S., DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase Journal of Biological Chemistry 2006 281 34 24161 24170 (Pubitemid 44274190)
36. Lhr K., Mritz C., Contente A., Dobbelstein M., p21/CDKN1A mediates negative regulation of transcription by p53 Journal of Biological Chemistry 2003 278 35 32507 32516 (Pubitemid 37055688)
37. Bargonetti J., Chicas A., White D., Prives C., p53 represses Sp1 DNA binding and HIV-LTR directed transcription Cellular and Molecular Biology 1997 43 7 935 949
38. Hoffman W. H., Biade S., Zilfou J. T., Chen J., Murphy M., Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 Journal of Biological Chemistry 2002 277 5 3247 3257 (Pubitemid 34953189)
39. Raj D., Liu T., Samadashwily G., Li F., Grossman D., Survivin repression by p53, Rb and E2F2 in normal human melanocytes Carcinogenesis 2008 29 1 194 201 (Pubitemid 351201759)
40. Jiang Y., Saavedra H. I., Holloway M. P., Leone G., Altura R. A., Aberrant regulation of survivin by the RB/E2F family of proteins Journal of Biological Chemistry 2004 279 39 40511 40520 (Pubitemid 39287642)
41. Dasgupta P., Kinkade R., Joshi B., DeCook C., Haura E., Chellappan S., Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin Proceedings of the National Academy of Sciences of the United States of America 2006 103 16 6332 6337
42. Nabilsi N. H., Broaddus R. R., Loose D. S., DNA methylation inhibits p53-mediated survivin repression Oncogene 2009 28 19 2046 2050
43. D'Souza S., Xin H., Walter S., Choubey D., The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression Journal of Biological Chemistry 2001 276 1 298 305 (Pubitemid 32050320)
44. Kho P. S., Wang Z., Zhuang L., Li Y., Chew J. L., Ng H. H., Liu E. T., Yu Q., p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis Journal of Biological Chemistry 2004 279 20 21183 21192 (Pubitemid 38656522)
45. Li C., Lin M., Liu J., Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis Oncogene 2004 23 58 9336 9347 (Pubitemid 40069666)
46. Arias-Lopez C., Lazaro-Trueba I., Kerr P., Lord C. J., Dexter T., Iravani M., Ashworth A., Silva A., p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene EMBO Reports 2006 7 2 219 224
47. Lazaro-Trueba I., Arias C., Silva A., Double bolt regulation of Rad51 by p53: a role for transcriptional repression Cell Cycle 2006 5 10 1062 1065 (Pubitemid 43765300)
48. Hsieh W. J., Hsieh S. C., Chen C. C., Wang F. F., Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage Biochemical and Biophysical Research Communications 2008 369 2 567 572
49. Habib G. M., p53 regulates Hsp90 during arsenite-induced cytotoxicity in glutathione-deficient cells Archives of Biochemistry and Biophysics 2009 481 1 101 109
50. Wang B., Feng P., Xiao Z., Ren EE. C., LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma Journal of Hepatology 2009 50 3 528 537
51. Xu D., Wang Q., Gruber A., Bjrkholm M., Chen Z., Zaid A., Selivanova G., Peterson C., Wiman K. G., Pisa P., Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells Oncogene 2000 19 45 5123 5133
52. Webster N. J. G., Resnik J. L., Reichart D. B., Strauss B., Haas M., Seely B. L., Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer Cancer Research 1996 56 12 2781 2788 (Pubitemid 26175738)
53. Ohlsson C., Kley N., Werner H., Leroith D., p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1 Endocrinology 1998 139 3 1101 1107 (Pubitemid 28510128)
54. Zhang L., Yu D., Hu M., Xiong S., Lang A., Ellis L. M., Pollock R. E., Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression Cancer Research 2000 60 13 3655 3661 (Pubitemid 30482190)
55. Suehiro T., Kaneda T., Ikeda Y., Ar K. II, Kumon Y., Hashimoto K., Regulation of human glucocorticoid receptor gene transcription by Sp1 and p53 Molecular and Cellular Endocrinology 2004 222 1-2 33 40 (Pubitemid 38900813)
56. Sun Y., Sun Y., Wenger L., Rutter J. L., Brinckerhoff C. E., Cheung H. S., p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression Journal of Biological Chemistry 1999 274 17 11535 11540
57. Sun Y., Zeng X. R., Wenger L., Firestein G. S., Cheung H. S., p53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex Journal of Cellular Biochemistry 2004 92 2 258 269
58. Krause K., Wasner M., Reinhard W., Haugwitz U., Lange-zu Dohna C., Mossner J., Engeland K., The tumour suppressor protein p53 can repress transcription of cyclin B Nucleic Acids Research 2000 28 22 4410 4418
59. Jung M. S., Yun J., Chae H. D., Kim J. M., Kim S. C., Choi T. S., Shin D. Y., p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor Oncogene 2001 20 41 5818 5825 (Pubitemid 32937951)
60. Labbe J. C., Lee M. G., Nurse P., Picard A., Doree M., Activation at M-phase of a protein kinase encoded by a starfish homologue of the cell cycle control gene cdc2 Nature 1988 335 6187 251 254
61. Yun J., Chae H. D., Choy H. E., Chung J., Yoo H. S., Han M. H., Shin D. Y., p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor Journal of Biological Chemistry 1999 274 42 29677 29682
62. Matsui T., Katsuno Y., Inoue T., Fujita F., Joh T., Niida H., Murakami H., Itoh M., Nakanishi M., Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y Journal of Biological Chemistry 2004 279 24 25093 25100 (Pubitemid 38756758)
63. Zhou Y., Mehta K. R., Choi A. P., Scolavino S., Zhang X., DNA damage-induced inhibition of securin expression is mediated by p53 Journal of Biological Chemistry 2003 278 1 462 470 (Pubitemid 36043597)
64. Joshi A. A., Wu Z., Reed R. F., Suttle D. P., Nuclear factor-Y binding to the topoisomerase II promoter is inhibited by both the p53 tumor suppressor and anticancer drugs Molecular Pharmacology 2003 63 2 359 367 (Pubitemid 36158371)
65. Wang Q., Zambetti G. P., Suttle D. P., Inhibition of DNA topoisomerase II gene expression by the p53 tumor suppressor Molecular and Cellular Biology 1997 17 1 389 397 (Pubitemid 26425628)
66. Zhu N., Gu L., Findley H. W., Zhou M., Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53 Biochemical and Biophysical Research Communications 2005 335 4 1272 1279 (Pubitemid 41215554)
67. Agoff S. N., Hou J., Linzer D. I. H., Wu B., Regulation of the human hsp70 promoter by p53 Science 1993 259 5091 84 87 (Pubitemid 23036091)
68. Fritsche M., Mundt M., Merkle C., Jhne R., Groner B., P53 suppresses cytokine induced, Stat5 mediated activation of transcription Molecular and Cellular Endocrinology 1998 143 1-2 143 154 (Pubitemid 28458751)
69. Blagosklonny M. V., An W. G., Romanova L. Y., Trepel J., Fojo T., Neckers L., p53 inhibits hypoxia-inducible factor-stimulated transcription Journal of Biological Chemistry 1998 273 20 11995 11998 (Pubitemid 28240554)
70. Yu C. L., Driggers P., Barrera-Hernandez G., Nunez S. B., Segars J. H., Cheng S. Y., The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways Biochemical and Biophysical Research Communications 1997 239 2 617 620 (Pubitemid 27489014)
71. Maeda Y., Seidel S. D., Wei G., Liu X., Sladek F. M., Repression of hepatocyte nuclear factor 4 by tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity Molecular Endocrinology 2002 16 2 402 410 (Pubitemid 34131234)
72. Maeda Y., Hwang-Verslues W. W., Wei G., Fukazawa T., Durbin M. L., Owen L. B., Liu X., Sladek F. M., Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4 (HNF4 ) gene Biochemical Journal 2006 400 2 303 313 (Pubitemid 44852043)
73. Horikoshi N., Usheva A., Chen J., Levine A. J., Weinmann R., Shenk T., Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression Molecular and Cellular Biology 1995 15 1 227 234 (Pubitemid 24379919)
74. Mack D. H., Vartikar J., Pipas J. M., Laimins L. A., Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53 Nature 1993 363 6426 281 283 (Pubitemid 23158535)
75. Seto E., Usheva A., Zambetti G. P., Momand J., Horikoshi N., Weinmann R., Levine A. J., Shenk T., Wild-type p53 binds to the TATA-binding protein and represses transcription Proceedings of the National Academy of Sciences of the United States of America 1992 89 24 12028 12032 (Pubitemid 23004778)
76. Truant R., Xiao H., Ingles C. J., Greenblatt J., Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein Journal of Biological Chemistry 1993 268 4 2284 2287 (Pubitemid 23057837)
77. Pietrzak M., Puzianowska-Kuznicka M., p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter Biological Chemistry 2008 389 4 383 393 (Pubitemid 351773909)
78. Wu Y., Mehew J. W., Heckman C. A., Arcinas M., Boxer L. M., Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene 2001 20 2 240 251 (Pubitemid 32150269)
79. Subbaramaiah K., Altorkil N., Chung W. J., Mestre J. R., Sampat A., Dannenberg A. J., Inhibition of cyclooxygenase-2 gene expression by p53 Journal of Biological Chemistry 1999 274 16 10911 10915
80. Ragimov N., Krauskopf A., Navot N., Rotter V., Oren M., Aloni Y., Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif Oncogene 1993 8 5 1183 1193 (Pubitemid 23129840)
81. Crighton D., Woiwode A., Zhang C., Mandavia N., Morton J. P., Warnock L. J., Milner JO., White R. J., Johnson D. L., p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB EMBO Journal 2003 22 11 2810 2820 (Pubitemid 36712376)
82. Farmer G., Friedlander P., Colgan J., Manley J. L., Prives C., Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein Nucleic Acids Research 1996 24 21 4281 4288 (Pubitemid 26377347)
83. Gridasova A. A., Henry R. W., The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding Molecular and Cellular Biology 2005 25 8 3247 3260 (Pubitemid 40464325)
84. Sadowski C. L., Henry R. W., Lobo S. M., Hernandez N., Targeting TBP to a non-TATA box cis-regulatory element: a TBP-containing complex activates transcription from snRNA promoters through the PSE Genes and Development 1993 7 8 1535 1548 (Pubitemid 23234347)
85. Mirza A., McGuirk M., Hockenberry T. N., Wu Q., Ashar H., Black S., Wen S. F., Wang L., Kirschmeier P., Bishop W. R., Nielsen L. L., Pickett C. B., Liu S., Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 2002 21 17 2613 2622 (Pubitemid 34478319)
86. Gurova K. V., Roklin O. W., Krivokrysenko V. I., Chumakov P. M., Cohen M. B., Feinstein E., Gudkov A. V., Expression of prostate specific antigen (PSA) is negatively regulated by p53 Oncogene 2002 21 1 153 157 (Pubitemid 34076388)
87. Ho J. S. L., Ma W., Mao D. Y. L., Benchimol S., p53-dependent transcriptional repression of c-myc is required for G cell cycle arrest Molecular and Cellular Biology 2005 25 17 7423 7431 (Pubitemid 41170106)
88. Ogden S. K., Lee K. C., Wernke-Dollries K., Stratton S. A., Aronow B., Barton M. C., p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression Journal of Biological Chemistry 2001 276 45 42057 42062
89. Cui R., Nguyen T. T., Taube J. H., Stratton S. A., Feuerman M. H., Barton M. C., Family members p53 and p73 act together in chromatin modification and direct repression of -fetoprotein transcription Journal of Biological Chemistry 2005 280 47 39152 39160 (Pubitemid 41713866)
90. Nguyen T. T., Cho K., Stratton S. A., Barton M. C., Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene Molecular and Cellular Biology 2005 25 6 2147 2157 (Pubitemid 40354615)
91. Wilkinson D. S., Ogden S. K., Stratton S. A., Piechan J. L., Nguyen T. T., Smulian G. A., Barton M. C., A direct intersection between p53 and transforming growth factor pathways targets chromatin modification and transcription repression of the -fetoprotein gene Molecular and Cellular Biology 2005 25 3 1200 1212 (Pubitemid 40165825)
92. Murphy M., Ahn J., Walker K. K., Hoffman W. H., Evans R. M., Levine A. J., George D. L., Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a Genes and Development 1999 13 19 2490 2501 (Pubitemid 29489641)
93. Murphy M., Hinman A., Levine A. J., Wild-type p53 negatively regulates the expression of a microtubule-associated protein Genes and Development 1996 10 23 2971 2980 (Pubitemid 26412524)
94. Li J., Tan M., Li L., Pamarthy D., Lawrence T. S., Sun Y., SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing Neoplasia 2005 7 4 312 323 (Pubitemid 40664220)
95. Chun A. C. S., Jin D. Y., Transcriptional regulation of mitotic checkpoint gene MAD1 by p53 Journal of Biological Chemistry 2003 278 39 37439 37450 (Pubitemid 37175264)
96. Estve P. O., Chin H. G., Pradhan S., Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters Proceedings of the National Academy of Sciences of the United States of America 2005 102 4 1000 1005 (Pubitemid 40170715)
97. Rother K., Johne C., Spiesbach K., Haugwitz U., Tschp K., Wasner M., Klein-Hitpass L., Mry T., Mssner J., Engeland K., Identification of Tcf-4 as a transcriptional target of p53 signalling Oncogene 2004 23 19 3376 3384 (Pubitemid 38669827)
98. Amundson S. A., Bittner M., Chen Y., Trent J., Meltzer P., Fornace A. J., Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses Oncogene 1999 18 24 3666 3672 (Pubitemid 29322393)
99. Ginsberg D., Mechta F., Yaniv M., Oren M., Wild-type p53 can down-modulate the activity of various promoters Proceedings of the National Academy of Sciences of the United States of America 1991 88 22 9979 9983 (Pubitemid 21915758)
100. Rocha S., Martin A. M., Meek D. W., Perkins N. D., p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF- B subunit with histone deacetylase 1 Molecular and Cellular Biology 2003 23 13 4713 4727 (Pubitemid 36740458)
101. Gottifredi V., Karni-Schmidt O., Shieh S. Y., Prives C., p53 down-regulates CHK1 through p21 and the retinoblastoma protein Molecular and Cellular Biology 2001 21 4 1066 1076 (Pubitemid 32114956)
102. Zhu H., Chang B. D., Uchiumi T., Roninson I. B., Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1) Cell Cycle 2002 1 1 59 66
103. De Toledo S. M., Azzam E. I., Keng P., Laffrenier S., Little J. B., Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, Thymidine Kinace, Topoisomerase II, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21(Waf1) Cell Growth and Differentiation 1998 9 11 887 896 (Pubitemid 28514284)
104. Flatt P. M., Tang L. J., Scatena C. D., Szak S. T., Pietenpol J. A., p53 regulation of G checkpoint is retinoblastoma protein dependent Molecular and Cellular Biology 2000 20 12 4210 4223 (Pubitemid 30346617)
105. Mannefeld M., Klassen E., Gaubatz S., B-MYB is required for recovery from the DNA damage-induced G checkpoint in p53 mutant cells Cancer Research 2009 69 9 4073 4080
106. Rother K., Kirschner R., Snger K., Bhlig L., Mssner J., Engeland K., p53 downregulates expression of the G/S cell cycle phosphatase Cdc25A Oncogene 2007 26 13 1949 1953 (Pubitemid 46474635)
107. Vigneron A., Cherier J., Barr B., Gamelin E., Coqueret O., The cell cycle inhibitor p21 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression Journal of Biological Chemistry 2006 281 46 34742 34750 (Pubitemid 46036514)
108. Shats I., Milyavsky M., Tang X., Stambolsky P., Erez N., Brosh R., Kogan I., Braunstein I., Tzukerman M., Ginsberg D., Rotter V., p53-dependent down-regulation of telomerase is mediated by p21 Journal of Biological Chemistry 2004 279 49 50976 50985 (Pubitemid 40017838)
109. Jackson M. W., Agarwal M. K., Yang J., Bruss P., Uchiumi T., Agarwal M. L., Stark G. R., Taylor W. R., p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2 Journal of Cell Science 2005 118 9 1821 1832 (Pubitemid 40723827)
110. Scian M. J., Carchman E. H., Mohanraj L., Stagliano K. E.R., Anderson M. A.E., Deb D., Crane B. M., Kiyono T., Windle B., Deb S. P., Deb S., Wild-type p53 and p73 negatively regulate expression of proliferation related genes Oncogene 2008 27 18 2583 2593 (Pubitemid 351550876)
111. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 1993 75 4 805 816 (Pubitemid 23346377)
112. Hiebert S. W., Chellappan S. P., Horowitz J. M., Nevins J. R., The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F Genes and Development 1992 6 2 177 185
113. Taylor W. R., Schnthal A. H., Galante J., Stark G. R., p130/E2F4 binds to and represses the cdc2 promoter in response to p53 Journal of Biological Chemistry 2001 276 3 1998 2006 (Pubitemid 32109679)
114. Spitkovsky D., Schulze A., Boye B., Jansen-Drr P., Down-regulation of Cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter Cell Growth and Differentiation 1997 8 6 699 710 (Pubitemid 27276400)
115. Mller G. A., Engeland K., The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription: review article FEBS Journal 2010 277 4 877 893
116. Kidokoro T., Tanikawa C., Furukawa Y., Katagiri T., Nakamura Y., Matsuda K., CDC20, a potential cancer therapeutic target, is negatively regulated by p53 Oncogene 2008 27 11 1562 1571 (Pubitemid 351347882)
117. Banerjee T., Nath S., Roychoudhury S., DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling Nucleic Acids Research 2009 37 8 2688 2698
118. Jackson J. G., Pereira-Smith O. M., Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells Molecular and Cellular Biology 2006 26 7 2501 2510
119. Polager S., Ginsberg D., E2F mediates sustained G arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress Journal of Biological Chemistry 2003 278 3 1443 1449 (Pubitemid 36801369)
120. Siddiqui H., Solomon D. A., Gunawardena R. W., Wang Y., Knudsen E. S., Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition Molecular and Cellular Biology 2003 23 21 7719 7731 (Pubitemid 37271470)
121. Spurgers K. B., Gold D. L., Coombes K. R., Bohnenstiehl N. L., Mullins B., Meyn R. E., Logothetis C. J., McDonnell T. J., Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression Journal of Biological Chemistry 2006 281 35 25134 25142 (Pubitemid 44401900)
122. Mahmoudi S., Henriksson S., Corcoran M., Mndez-Vidal C., Wiman K. G., Farnebo M., Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage Molecular Cell 2009 33 4 462 471
123. Candeias M. M., Malbert-Colas L., Powell D. J., Daskalogianni C., Maslon M. M., Naski N., Bourougaa K., Calvo F., Fhraeus R., p53 mRNA controls p53 activity by managing Mdm2 functions Nature Cell Biology 2008 10 9 1098 1105
124. Bommer G. T., Gerin I., Feng Y., Kaczorowski A. J., Kuick R., Love R. E., Zhai Y., Giordano T. J., Qin Z. S., Moore B. B., MacDougald O. A., Cho K. R., Fearon E. R., p53-mediated activation of miRNA34 candidate tumor-suppressor genes Current Biology 2007 17 15 1298 1307 (Pubitemid 47176893)
125. He L., He X., Lim L. P., De Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A. L., Linsley P. S., Chen C., Lowe S. W., Cleary M. A., Hannon G. J., A microRNA component of the p53 tumour suppressor network Nature 2007 447 7148 1130 1134 (Pubitemid 47014436)
126. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H., Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G -arrest Cell Cycle 2007 6 13 1586 1593 (Pubitemid 47327945)
127. Chang T. C., Wentzel E. A., Kent O. A., Ramachandran K., Mullendore M., Lee K., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C. J., Arking D., Beer M. A., Maitra A., Mendell J. T., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Molecular Cell 2007 26 5 745 752 (Pubitemid 46856245)
128. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M., Transcriptional activation of miR-34a contributes to p53-mediated apoptosis Molecular Cell 2007 26 5 731 743 (Pubitemid 46856247)
129. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297
130. Eulalio A., Huntzinger E., Izaurralde E., Getting to the root of miRNA-mediated gene silencing Cell 2008 132 1 9 14
131. Baek D., Villn J., Shin C., Camargo F. D., Gygi S. P., Bartel D. P., The impact of microRNAs on protein output Nature 2008 455 7209 64 71
132. Selbach M., Schwanhusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N., Widespread changes in protein synthesis induced by microRNAs Nature 2008 455 7209 58 63
133. Guo H., Ingolia N. T., Weissman J. S., Bartel D. P., Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 2010 466 7308 835 840
134. Braun C. J., Zhang X., Savelyeva I., Wolff S., Moll U. M., Schepeler T., rntoft T. F., Andersen C. L., Dobbelstein M., p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest Cancer Research 2008 68 24 10094 10104
135. Georges S. A., Biery M. C., Kim S. Y., Schelter J. M., Guo J., Chang A. N., Jackson A. L., Carleton M. O., Linsley P. S., Cleary M. A., Chau B. N., Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215 Cancer Research 2008 68 24 10105 10112
136. Bohlig L., Friedrich M., Engeland K., p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins Nucleic Acids Research 2011 39 2 440 453
137. Takahashi Y., Forrest A. R. R., Maeno E., Hashimoto T., Daub C. O., Yasuda J., MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines PLoS One 2009 4 8
138. Yamakuchi M., Lotterman C. D., Bao C., Hruban R. H., Karim B., Mendell J. T., Huso D., Lowenstein C. J., P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis Proceedings of the National Academy of Sciences of the United States of America 2010 107 14 6334 6339
139. Brosh R., Shalgi R., Liran A., Landan G., Korotayev K., Nguyen G. H., Enerly E., Johnsen H., Buganim Y., Solomon H., Goldstein I., Madar S., Goldfinger N., Brresen-Dale A. L., Ginsberg D., Harris C. C., Pilpel Y., Oren M., Rotter V., p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation Molecular Systems Biology 2008 4
140. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y. Y., p53 represses c-Myc through induction of the tumor suppressor miR-145 Proceedings of the National Academy of Sciences of the United States of America 2009 106 9 3207 3212
141. Yan H. L., Xue G., Mei Q., Wang Y. Z., Ding F. X., Liu M. F., Lu M. H., Tang Y., Yu H. Y., Sun S. H., Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis EMBO Journal 2009 28 18 2719 2732
142. Guttman M., Amit I., Garber M., French C., Lin M. F., Feldser D., Huarte M., Zuk OR., Carey B. W., Cassady J. P., Cabili M. N., Jaenisch R., Mikkelsen T. S., Jacks T., Hacohen N., Bernstein B. E., Kellis M., Regev A., Rinn J. L., Lander E. S., Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals Nature 2009 458 7235 223 227
143. Khalil A. M., Guttman M., Huarte M., Garber M., Raj A., Morales D. R., Thomas K., Presser A., Bernstein B. E., Van Oudenaarden A., Regev A., Lander E. S., Rinn J. L., Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression Proceedings of the National Academy of Sciences of the United States of America 2009 106 28 11667 11672
144. Huarte M., Guttman M., Feldser D., Garber M., Koziol M. J., Kenzelmann-Broz D., Khalil A. M., Zuk O., Amit I., Rabani M., Attardi L. D., Regev A., Lander E. S., Jacks T., Rinn J. L., A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response Cell 2010 142 3 409 419
145. Wang B., Xiao Z., Ko H. L., Ren E. C., The p53 response element and transcriptional repression Cell Cycle 2010 9 5 870 879
146. Murray-Zmijewski F., Slee E. A., Lu X., A complex barcode underlies the heterogeneous response of p53 to stress Nature Reviews Molecular Cell Biology 2008 9 9 702 712
147. Moskovits N., Kalinkovich A., Bar J., Lapidot T., Oren M., p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts Cancer Research 2006 66 22 10671 10676 (Pubitemid 44876961)
148. Pesch J., Brehm U., Staib C., Grummt F., Repression of interleukin-2 and interleukin-4 promoters by tumor suppressor protein p53 Journal of Interferon and Cytokine Research 1996 16 8 595 600 (Pubitemid 26307018)
149. Santhanam U., Ray A., Sehgal P. B., Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product Proceedings of the National Academy of Sciences of the United States of America 1991 88 17 7605 7609 (Pubitemid 21915202)
150. Ahn J., Murphy M., Kratowicz S., Wang A., Levine A. J., George D. L., Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction Oncogene 1999 18 43 5954 5958 (Pubitemid 29520452)
151. Mercer W. E., Shields M. T., Lin D., Appella E., Ullrich S. J., Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression Proceedings of the National Academy of Sciences of the United States of America 1991 88 5 1958 1962 (Pubitemid 21916346)
152. Harris L. C., Remack J. S., Houghton P. J., Brent T. P., Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene Cancer Research 1996 56 9 2029 2032 (Pubitemid 26119903)
153. Iotsova V., Crpieux P., Montpellier C., Laudet V., Stehelin D., TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53 Oncogene 1996 13 11 2331 2337 (Pubitemid 27026016)
154. Rother K., Li Y. Y., Tschp K., Kirschner R., Mller G. A., Mssner J., Engeland K., Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73 Cell Cycle 2007 6 7 853 862 (Pubitemid 46572628)
155. Rother K., Dengl M., Lorenz J., Tschp K., Kirschner R., Mssner J., Engeland K., Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73 FEBS Letters 2007 581 6 1166 1172 (Pubitemid 46385940)
156. Arizti P., Fang L., Park I., Yin Y., Solomon E., Ouchi T., Aaronson S. A., Lee S. W., Tumor suppressor p53 is required to modulate BRCA1 expression Molecular and Cellular Biology 2000 20 20 7450 7459
157. MacLachlan T. K., Dash B. C., Dicker D. T., El-Deiry W. S., Repression of BRCA1 through a feedback loop involving p53 Journal of Biological Chemistry 2000 275 41 31869 31875
158. Singh B., Reddy P. G., Goberdhan A., Walsh C., Dao SU., Ngai I., Chou T. C., O-charoenrat P., Levine A. J., Rao P. H., Stoffel A., p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas Genes and Development 2002 16 8 984 993 (Pubitemid 34408547)
159. Sengupta S., Shimamoto A., Koshiji M., Pedeux R., Rusin M., Spillare E. A., Shen J. C., Huang L. E., Lindor N. M., Furuichi Y., Harris C. C., Tumor suppressor p53 represses transcription of RECQ4 helicase Oncogene 2005 24 10 1738 1748 (Pubitemid 40461130)
160. Criswell T., Klokov D., Beman M., Lavik J. P., Boothman D. A., Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein Cancer Biology and Therapy 2003 2 4 372 380
161. Luo X., He Q., Huang Y., Sheikh M. S., Cloning and characterization of a p53 and DNA damage down-regulated gene PIQ that codes for a novel calmodulin-binding IQ motif protein and is up-regulated in gastrointestinal cancers Cancer Research 2005 65 23 10725 10733 (Pubitemid 41713340)
162. Sohr S., Engeland K., RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53 Cell Cycle 2008 7 21 3448 3460